Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 23

1.

Nitrofurantoin contraindication in patients with a creatinine clearance below 60 mL/min: looking for the evidence.

Oplinger M, Andrews CO.

Ann Pharmacother. 2013 Jan;47(1):106-11. doi: 10.1345/aph.1R352. Epub 2013 Jan 22. Review.

PMID:
23341159
2.

Nitrofurantoin-induced hepatotoxicity: a rare yet serious complication.

Sakaan SA, Twilla JD, Usery JB, Winton JC, Self TH.

South Med J. 2014 Feb;107(2):107-13. doi: 10.1097/SMJ.0000000000000059. Review.

PMID:
24926677
3.

[Nitrofurantoin--clinical relevance in uncomplicated urinary tract infections].

Stock I.

Med Monatsschr Pharm. 2014 Jul;37(7):242-8. Review. German.

PMID:
25065160
4.

Long-term antibiotics for preventing recurrent urinary tract infection in children.

Williams GJ, Wei L, Lee A, Craig JC.

Cochrane Database Syst Rev. 2006 Jul 19;(3):CD001534. Review. Update in: Cochrane Database Syst Rev. 2011;(3):CD001534.

PMID:
16855971
5.

Adverse reactions of nitrofurantoin, trimethoprim and sulfamethoxazole in children.

Karpman E, Kurzrock EA.

J Urol. 2004 Aug;172(2):448-53. Review.

PMID:
15247700
6.

Functional range of creatinine clearance for renal drug dosing: a practical solution to the controversy of which weight to use in the Cockcroft-Gault equation.

Brown DL, Masselink AJ, Lalla CD.

Ann Pharmacother. 2013 Jul-Aug;47(7-8):1039-44. doi: 10.1345/aph.1S176. Epub 2013 Jun 11. Review.

PMID:
23757387
7.

Capecitabine: a review.

Walko CM, Lindley C.

Clin Ther. 2005 Jan;27(1):23-44. Review.

PMID:
15763604
8.

Long-term antibiotics for preventing recurrent urinary tract infection in children.

Williams GJ, Lee A, Craig JC.

Cochrane Database Syst Rev. 2001;(4):CD001534. Review. Update in: Cochrane Database Syst Rev. 2006;(3):CD001534.

PMID:
11687116
9.

Long-term antibiotics for preventing recurrent urinary tract infection in children.

Williams G, Craig JC.

Cochrane Database Syst Rev. 2011 Mar 16;(3):CD001534. doi: 10.1002/14651858.CD001534.pub3. Review.

PMID:
21412872
10.

Drug therapy reviews: nitrofurantoin.

Gleckman R, Alvarez S, Joubert DW.

Am J Hosp Pharm. 1979 Mar;36(3):342-51. Review.

PMID:
369367
11.
12.

['Urinary tract infections'--revised CBO guideline. Dutch Institute for Quality Assurance].

van den Broek PJ, van Everdingen JJ.

Ned Tijdschr Geneeskd. 1999 Dec 4;143(49):2461-5. Review. Dutch.

PMID:
10608984
13.

Uncomplicated urinary tract infection in women. Current practice and the effect of antibiotic resistance on empiric treatment.

Nicolle L, Anderson PA, Conly J, Mainprize TC, Meuser J, Nickel JC, Senikas VM, Zhanel GG.

Can Fam Physician. 2006 May;52:612-8. Review.

14.

Prophylactic antibiotics to reduce the risk of urinary tract infections after urodynamic studies.

Foon R, Toozs-Hobson P, Latthe P.

Cochrane Database Syst Rev. 2012 Oct 17;10:CD008224. doi: 10.1002/14651858.CD008224.pub2. Review.

PMID:
23076941
15.
16.

Antimicrobial agents for treating uncomplicated urinary tract infection in women.

Zalmanovici Trestioreanu A, Green H, Paul M, Yaphe J, Leibovici L.

Cochrane Database Syst Rev. 2010 Oct 6;(10):CD007182. doi: 10.1002/14651858.CD007182.pub2. Review.

PMID:
20927755
17.

[Urinary tract infections: cystitis, pyelonephritis, urosepsis].

Fünfstück R, Wagenlehner FM, Olschläger T, Naber KG.

Dtsch Med Wochenschr. 2012 Feb;137(5):198-201. doi: 10.1055/s-0031-1292886. Epub 2012 Jan 25. Review. German. No abstract available.

PMID:
22278690
18.

Antibacterial prophylaxis in children with urinary tract infection.

Bollgren I.

Acta Paediatr Suppl. 1999 Nov;88(431):48-52. Review.

PMID:
10588271
19.

The safety profile of dalfampridine extended release in multiple sclerosis clinical trials.

Cornblath DR, Bienen EJ, Blight AR.

Clin Ther. 2012 May;34(5):1056-69. doi: 10.1016/j.clinthera.2012.03.007. Epub 2012 Apr 11. Review.

PMID:
22497693
20.

Recommended treatment for urinary tract infection in pregnancy.

Vercaigne LM, Zhanel GG.

Ann Pharmacother. 1994 Feb;28(2):248-51. Review.

PMID:
8173146
Items per page

Supplemental Content

Write to the Help Desk